SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
Validation of an exome and transcriptome based diagnostic platform enabling clinical cancer therapy selection and emerging composite biomarkers for immunotherapy. This is an ASCO Meeting Abstract from ...
Each year, the uptake and utilization of automation in the clinical laboratory is increasing at a rate of over 30%. This is rapidly advancing the development of new technologies and driving the early ...
Precision Dx Products include Twist Precision Prep and Enrichment Dx Kit, Twist Precision Exome Dx Panel and Twist Precision Exome Dx Kit SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results